OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang is departing the company to create an artificial-intelligence-driven drug-discovery startup. The venture is being discussed at a valuation of roughly two billion dollars, with plans to raise about two hundred million dollars in financing. The startup’s name has not yet been disclosed.

Aus allen unten stehenden Berichten verfasst, nicht aus einem einzelnen.